Specific Populations No clinically significant differences in semaglutide pharmacokinetics were observed based on age (18 years old), sex, race (White, Asian or Black or African American), ethnicity, body weight (40 to 188 kg), upper GI disease (i.e., chronic gastritis and/or gastroesophageal reflux disease), hepatic impairment (i.e., mild, moderate, severe based on the Child-Pugh system) and renal impairment (i.e., mild, moderate, severe, end staged renal disease)
Fact: Many patients find that as their technique improves and they learn which injection sites work best for their bodies, the frequency of bruising decreases significantly
For each new dose, move to a different exact spot
At the time, she could only order one box per day